Alzheimer's Drug Discovery Foundation Investor

Provides funding to leading scientists who are conducting the most promising, innovative Alzheimer’s drug research worldwide.
Technology: Cancer
Industry: Investor
Headquarters: New York, New York, United States
Founded Date: 1998-01-01
Employees Number: 11-50
Investor Type: Venture Capital
Number Of Exits: 6
Investors Number: 25
Estimated Revenue: $1M to $10M

Visit Website
Register and Claim Ownership